Suppr超能文献

用天然肺表面活性剂分散单壁碳纳米管进行肺体外和体内毒性研究。

Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies.

机构信息

National Institute for Occupational Safety and Health, HELD/PPRB, Morgantown, WV 26505, USA.

出版信息

Part Fibre Toxicol. 2010 Oct 19;7:31. doi: 10.1186/1743-8977-7-31.

Abstract

BACKGROUND

Accumulating evidence indicate that the degree of dispersion of nanoparticles has a strong influence on their biological activities. The aims of this study were to develop a simple and rapid method of nanoparticle dispersion using a natural lung surfactant and to evaluate the effect of dispersion status of SWCNT on cytotoxicity and fibrogenicity in vitro and in vivo.

RESULTS

The natural lung surfactant Survanta® was used to disperse single-walled carbon nanotubes (SWCNT) in a biological medium. At physiologically relevant concentrations, Survanta® produced well dispersed SWCNT without causing a cytotoxic or fibrogenic effect. In vitro studies show that Survanta®-dispersed SWCNT (SD-SWCNT) stimulated proliferation of lung epithelial cells at low doses (0.04-0.12 μg/ml or 0.02-0.06 μg/cm² exposed surface area) but had a suppressive effect at high doses. Non-dispersed SWCNT (ND-SWCNT) did not exhibit these effects, suggesting the importance of dispersion status of SWCNT on bioactivities. Studies using cultured human lung fibroblasts show that SD-SWCNT stimulated collagen production of the cells. This result is supported by a similar observation using Acetone/sonication dispersed SWCNT (AD-SWCNT), suggesting that Survanta® did not mask the bioactivity of SWCNT. Likewise, in vivo studies show that both SD-SWCNT and AD-SWCNT induced lung fibrosis in mice, whereas the dispersing agent Survanta® alone or Survanta®-dispersed control ultrafine carbon black had no effect.

CONCLUSIONS

The results indicate that Survanta® was effective in dispersing SWCNT in biological media without causing cytotoxic effects at the test concentrations used in this study. SD-SWCNT stimulated collagen production of lung fibroblasts in vitro and induced lung fibrosis in vivo. Similar results were observed with AD-SWCNT, supporting the conclusion that Survanta® did not mask the bioactivities of SWCNT and thus can be used as an effective dispersing agent. Since excessive collagen production is a hallmark of lung fibrosis, the results of this study suggest that the in vitro model using lung fibroblasts may be an effective and rapid screening tool for prediction of the fibrogenic potential of SWCNT in vivo.

摘要

背景

越来越多的证据表明,纳米颗粒的分散程度对其生物活性有很强的影响。本研究的目的是开发一种使用天然肺表面活性剂简单快速地分散纳米颗粒的方法,并评估分散状态对单壁碳纳米管(SWCNT)在体外和体内的细胞毒性和纤维生成性的影响。

结果

天然肺表面活性剂 Survanta®被用于在生物介质中分散单壁碳纳米管(SWCNT)。在生理相关浓度下,Survanta®产生了良好分散的 SWCNT,而没有引起细胞毒性或纤维生成作用。体外研究表明,Survanta®分散的 SWCNT(SD-SWCNT)在低剂量(0.04-0.12μg/ml 或 0.02-0.06μg/cm²暴露表面积)下刺激肺上皮细胞增殖,但在高剂量下具有抑制作用。未分散的 SWCNT(ND-SWCNT)没有表现出这些作用,这表明 SWCNT 的分散状态对其生物活性很重要。使用培养的人肺成纤维细胞的研究表明,SD-SWCNT 刺激细胞胶原蛋白的产生。这一结果得到了使用丙酮/超声分散的 SWCNT(AD-SWCNT)的类似观察结果的支持,这表明 Survanta®没有掩盖 SWCNT 的生物活性。同样,体内研究表明,SD-SWCNT 和 AD-SWCNT 都能诱导小鼠肺纤维化,而单独的分散剂 Survanta®或 Survanta®分散的对照超细炭黑没有作用。

结论

结果表明,Survanta®在本研究中使用的测试浓度下在生物介质中有效地分散 SWCNT,而没有引起细胞毒性作用。SD-SWCNT 刺激体外肺成纤维细胞胶原蛋白的产生,并在体内诱导肺纤维化。用 AD-SWCNT 也观察到类似的结果,这支持了 Survanta®没有掩盖 SWCNT 的生物活性的结论,因此可以用作有效的分散剂。由于胶原蛋白的过度产生是肺纤维化的一个标志,本研究的结果表明,使用肺成纤维细胞的体外模型可能是预测 SWCNT 在体内纤维生成潜力的一种有效和快速的筛选工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e17/2970581/b07cdd2c06ff/1743-8977-7-31-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验